Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Xingguo Hou"'
Publikováno v:
Journal of Isotopes, Vol 37, Iss 4, Pp 387-393 (2024)
To provide a method for the production of 124I by using a medical cyclotron and the method of 124I labeling, 124I was prepared using a nuclear reaction of 124Te (p，n) 124I. Firstly，a 124TeO2/Al2O3 target was obtained by pressing，and then bombar
Externí odkaz:
https://doaj.org/article/b5315c2c484b467bb2379cb6be377570
Autor:
Xingguo Hou, Song Liu, Ziqing Zeng, Zilei Wang, Jin Ding, Yan Chen, Xiangyu Gao, Jianghua Wang, Guanxi Xiao, Baiyong Li, Hua Zhu, Zhi Yang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 175, Iss , Pp 116669- (2024)
Background: The lack of an efficient way to screen patients who are responsive to immunotherapy challenges PD1/CTLA4-targeting cancer treatment. Immunotherapeutic efficacy cannot be clearly determined by peripheral blood analyses, tissue gene markers
Externí odkaz:
https://doaj.org/article/13404cc6508345a7bca0ac26b12a45c3
Autor:
Yuan Yao, Yanan Ren, Xingguo Hou, Jinyu Zhu, Xiaokun Ma, Song Liu, Teli Liu, Qian Zhang, Xiaopan Ma, Zhi Yang, Hua Zhu, Nan Li
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 168, Iss , Pp 115602- (2023)
Objectives: The aim of this study was to design a novel tracer targeting programmed cell death-ligand 2 (PD-L2) to dynamically monitor PD-L2 expression and perform preclinical screening to identify patients who may benefit from immune checkpoint inhi
Externí odkaz:
https://doaj.org/article/76e1de395c7f4e24b20a827cc50674de
Autor:
Yan Chen, Xingguo Hou, Dapeng Li, Jin Ding, Jiayue Liu, Zilei Wang, Fei Teng, Hongjun Li, Fan Zhang, Yi Gu, Steven Yu, Xueming Qian, Zhi Yang, Hua Zhu
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 13, Iss 4, Pp 367-375 (2023)
Claudin18.2 (CLDN18.2) is a tight junction protein that is overexpressed in a variety of solid tumors such as gastrointestinal cancer and oesophageal cancer. It has been identified as a promising target and a potential biomarker to diagnose tumor, ev
Externí odkaz:
https://doaj.org/article/77e85538b05d490ba417434da0a4bce5
Autor:
Song Liu, Guanghui Li, Lei Ding, Jin Ding, Qian Zhang, Dan Li, Xingguo Hou, Xiangxing Kong, Jing Zou, Shiming Zhang, Hongbin Han, Yakun Wan, Zhi Yang, Hua Zhu
Publikováno v:
Research, Vol 2022 (2022)
Due to the rapid spread of coronavirus disease 2019 (COVID-19), there is an urgent requirement for the development of additional diagnostic tools for further analysis of the disease. The isolated nanobody Nb11-59 binds to the severe acute respiratory
Externí odkaz:
https://doaj.org/article/b7c4612a778a4c6982a87bf57897f3d4
Autor:
Changsong Qi, Rui Guo, Yan Chen, Chenzhen Li, Chang Liu, Miao Zhang, Cheng Zhang, Xiaotian Zhang, Xingguo Hou, Bo Chen, Bing Jia, Zhi Yang, Lin Shen, Hua Zhu
Publikováno v:
Journal of Nuclear Medicine; Aug2024, Vol. 65 Issue 8, p1-8, 8p
Autor:
Pei Wang, Shuailiang Wang, Futao Liu, Ya’nan Ren, Qian Guo, Qian Zhang, XingGuo Hou, Yuan Yao, Hua Zhu, Zhi Yang
Publikováno v:
Molecular Pharmaceutics. 20:1415-1425
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d60b842f3bc14d98ea595017994df33b
https://doi.org/10.1021/acs.molpharmaceut.2c01000
https://doi.org/10.1021/acs.molpharmaceut.2c01000
Autor:
Yuan Yao, Xingguo Hou, Song Liu, Teli Liu, Yanan Ren, Xiaokun Ma, Qian Zhang, Pei Wang, Qian Guo, Xiaopan Ma, Zhi Yang, Hua Zhu, Nan Li
Publikováno v:
Molecular Pharmaceutics. 20:1365-1374
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15a513a95df7f0a62be5a2aa0d1fe5ee
https://doi.org/10.1021/acs.molpharmaceut.2c00958
https://doi.org/10.1021/acs.molpharmaceut.2c00958
Autor:
Qian Guo, Chuanke Zhao, Xiangyu Gao, Lixin Ding, Pei Wang, Ya’nan Ren, Xingguo Hou, Yuan Yao, Cheng Zhang, Xianteng Yang, Zhi Yang, Hua Zhu
Publikováno v:
Molecular Pharmaceutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0edbb4bca95a07c9b3f3731d2fa940e
https://doi.org/10.1021/acs.molpharmaceut.3c00299
https://doi.org/10.1021/acs.molpharmaceut.3c00299
Autor:
Dan Li, Feng Wang, Jinquan Jiang, Xingguo Hou, Jin Ding, Zilei Wang, Yan Chen, Teli Liu, Zhi Yang, Hua Zhu
Publikováno v:
Molecular pharmaceutics. 19(11)
Programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1), the research focus in immune checkpoint regulation, play an important role in tumor immunotherapy. Inhibitors of this pathway are also the focus of tumor immunotherapy research. The PD-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a15cea09c2fad1aa3b64c4b994cbeba9
https://pubmed.ncbi.nlm.nih.gov/36268880
https://pubmed.ncbi.nlm.nih.gov/36268880